Ultragenyx Pharmaceutical
RARE
RARE
158 hedge funds and large institutions have $2.56B invested in Ultragenyx Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 81 increasing their positions, 40 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $2.76B → $2.56B (-$201M)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
158
Holding in Top 10
1
Calls
$15.7M
Puts
$4.83M
Top Buyers
| 1 | +$41.4M | |
| 2 | +$20.6M | |
| 3 | +$20.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$16.8M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12.6M |
Top Sellers
| 1 | -$143M | |
| 2 | -$18.7M | |
| 3 | -$7.73M | |
| 4 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
-$6.94M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$5.73M |